9989 fundamentals
An in-depth look to SHENZHEN HEPALINK PHARMACEUTICAL operating, investing, and financing activities
9989 free cash flow for Q1 24 is 906.7 M HKD. For 2023, 9989 free cash flow was 29.29 M HKD and operating cash flow was 520.88 M HKD.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q4 '23
Q1 '24
TTM